Horizon Space Acquisition II Corp. 8-K

What Happened

• Horizon Space Acquisition II Corp. (HSPT) filed an 8‑K reporting shareholder votes at two extraordinary general meetings in February 2026. On February 12, 2026 shareholders approved the proposed business combination with SL BIO Ltd. (via SL Science Holding Ltd. and merger subsidiaries) and the related transaction documents. On February 13, 2026 shareholders approved amendments to the company’s memorandum and articles and to its Investment Management Trust Agreement to allow extending the SPAC termination date.
• After shareholder approval, HSPT and Wilmington Trust, N.A. executed the Trust Agreement amendment on February 17, 2026. The company’s amended governance lets HSPT extend its deadline to complete an initial business combination from February 18, 2026 up to February 18, 2027 via up to twelve one‑month extensions.

Key Details

• Business Combination vote (Feb 12, 2026): 5,031,013 FOR, 1,166,644 AGAINST; ~68.26% of 9,080,000 shares were voted.
• Extension vote (Feb 13, 2026): 5,735,413 FOR, 916,398 AGAINST; ~73.26% of 9,080,000 shares were voted.
• Termination Date originally Feb 18, 2026; may be extended up to 12 one‑month extensions (through Feb 18, 2027) without further shareholder approval.
• Trust Amendment requires the Trustee to liquidate the trust account only after receiving an instruction letter upon closing or if HSPT cannot complete a business combination by the Termination Date, provided HSPT funds the trust each month by the lesser of (i) $50,000 total or (ii) $0.033 per remaining public share.

Why It Matters

• The shareholder approvals clear two major hurdles: the contemplated merger with SL Bio (the business combination) and the mechanism to extend the SPAC’s deadline, giving HSPT more time to close the transaction.
• The Trust Amendment and monthly funding requirement affect how and when the trust account can be liquidated and indicate the company will need to contribute cash monthly to preserve the extension period. That affects the timetable and available cash tied up in the SPAC trust.
• Investors should note the business combination remains subject to closing conditions and contains forward‑looking statements; outcomes (including listing status, cash available after redemptions, and timing) may change and are described in HSPT’s proxy and SEC filings.